TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26797725

Group type: EXPERIMENTAL
Intervention: Body scan mindfulness meditation (MM)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Slow breathing (SB) with a biofeedback device
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mindful awareness of the breath with an intention to slow the breath (MM+SB)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Sitting quietly (SQ)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Meditation arms (MM, SB, MM+SB)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MM compared with MM+SB and SB
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MM, MM+SB, and SQ
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MM
Number of subjects: 102
Study: 24393287

Group type: EXPERIMENTAL
Intervention: Web-based educational intervention for delirium
Number of subjects: 0
Study: 22566588

Group type: EXPERIMENTAL
Intervention: Ritonavir 100 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Ritonavir 50 mg
Number of subjects: 13
Study: 20439216

Group type: EXPERIMENTAL
Intervention: Physical activity (walking 10,000 steps per day)
Number of subjects: 36
Study: 17645681

Group type: EXPERIMENTAL
Intervention: FACT-G based algorithm
Number of subjects: 1433
Study: 16163514

Group type: EXPERIMENTAL
Intervention: Femoral Ring Allograft (FRA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Titanium Cage (TC)
Number of subjects: 78
Study: 12322788

Group type: EXPERIMENTAL
Intervention: Taurine/Diltiazem/Vitamin E
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 10447324

Group type: EXPERIMENTAL
Intervention: Sacolene (4 g at start and 2 g 4 hourly until cessation of diarrhoea)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 7818105

Group type: EXPERIMENTAL
Intervention: Nitrous oxide anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: No nitrous oxide anesthesia (control group)
Number of subjects: 60
Study: 1708037

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8654
Study: 372858

Group type: EXPERIMENTAL
Intervention: gamma-ethylester of glutamic acid (25 g)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: l-arginine (25 g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: placebo (physiological solution in identical 500 ml bottles)
Number of subjects: 45
Study: 31915052

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS)
Number of subjects: 250

Group type: COMPARATOR
Intervention: No POCUS (control group)
Number of subjects: 250
Study: 30371811

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (transfuse hemoglobin <7 g/dL) in massive burns
Number of subjects: 345

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfuse hemoglobin <10 g/dL) in massive burns
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy in major burns
Number of subjects: 345

Group type: COMPARATOR
Intervention: Liberal transfusion strategy in major burns
Number of subjects: 345
Study: 29734777

Group type: EXPERIMENTAL
Intervention: Sunrouge extract containing 11.2 mg anthocyanin and 323.6 mg EGCG
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Yabukita extract containing 322.2 mg EGCG
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo group receiving barley extract without catechin
Number of subjects: 120
Study: 26887587

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 0
Study: 24941177

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg
Number of subjects: 958

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 958

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 958
Study: 21805328

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (160 mg daily for up to 6 months)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 32
Study: 19440700

Group type: EXPERIMENTAL
Intervention: 0.6 g/kg ethanol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 40
Study: 17456652

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.0625 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.125 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.0 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Dexamethasone (all doses)
Number of subjects: 125
Study: 15178381

Group type: EXPERIMENTAL
Intervention: Inductive reasoning tasks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Deductive reasoning tasks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Reasoning Type (deduction and induction) by Task (reasoning and baseline) interaction
Number of subjects: 16
Study: 11508019

Group type: EXPERIMENTAL
Intervention: Professional attire
Number of subjects: 38

Group type: COMPARATOR
Intervention: Casual attire
Number of subjects: 38
Study: 9241003

Group type: EXPERIMENTAL
Intervention: Brofaromine (50 mg/day titrated to 150 mg/day)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 8390340

Group type: EXPERIMENTAL
Intervention: Gonadotropin releasing hormone agonist (GnRHA) with low doses of oral estrogen (0.625 mg conjugated estrogen, CE for 6 days/week) and intermittent oral progestogen (10 mg medroxyprogesterone acetate, MPA for 13 days every 4 months)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 18
Study: 2892259

Group type: EXPERIMENTAL
Intervention: Nizatidine (150 mg h.s.)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study: 31072380

Group type: EXPERIMENTAL
Intervention: Autologous mesenchymal stem cells (MSC) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26938761

Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation (RFTC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Regular treatments (Control)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups (Cases and Controls)
Number of subjects: 54
Study: 24903908

Group type: EXPERIMENTAL
Intervention: 24-week resistance-type exercise training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 100
Study: 24161413

Group type: EXPERIMENTAL
Intervention: Oral cholera vaccine (Shanchol™), two doses
Number of subjects: 172754

Group type: EXPERIMENTAL
Intervention: Vaccine plus safe water and hand washing practice
Number of subjects: 172754

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 172754
Study: 21276188

Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Electrical acupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nonpenetrating sham acupuncture (NPSA) with simulated manual stimulation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nonpenetrating sham acupuncture (NPSA) with simulated electrical stimulation
Number of subjects: 45
Study: 19451353

Group type: EXPERIMENTAL
Intervention: Vitamin E (402 mg every other day)
Number of subjects: 2824

Group type: EXPERIMENTAL
Intervention: Beta carotene (50 mg every other day)
Number of subjects: 2824

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg daily)
Number of subjects: 2824
Study: 16756056

Group type: EXPERIMENTAL
Intervention: Clinott‐P (generic clindamycin)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dalacin C (original preparation)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both Clinott‐P and Dalacin C
Number of subjects: 24
Study: 15531858

Group type: EXPERIMENTAL
Intervention: 50 mg/day oral isoflavones
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 75 mg/day oral isoflavones
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 12 mg/day transdermal isoflavones
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 6 mg/day transdermal isoflavones
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 11745230

Group type: EXPERIMENTAL
Intervention: Combination therapy with transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Percutaneous ethanol injection (PEI) alone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination therapy with TACE-PEI
Number of subjects: 52

Group type: COMPARATOR
Intervention: PEI alone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination therapy with TACE-PEI (for tumors < 2 cm)
Number of subjects: 52

Group type: COMPARATOR
Intervention: PEI alone (for tumors < 2 cm)
Number of subjects: 52
Study: 8976640

Group type: EXPERIMENTAL
Intervention: Intra-articular methyl prednisolone acetate
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 1420751

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 6363216

Group type: EXPERIMENTAL
Intervention: Injection sclerotherapy at intervals of one week
Number of subjects: 55

Group type: COMPARATOR
Intervention: Injection sclerotherapy at intervals of three weeks
Number of subjects: 55
Study: 31842811

Group type: EXPERIMENTAL
Intervention: Vaginal dose of radical radiotherapy (using PIBS point system)
Number of subjects: 936
Study: 30232662

Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) stoves
Number of subjects: 200
Study: 27084856

Group type: EXPERIMENTAL
Intervention: Test group (final abutment placed and tightened to 30 Ncm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healing abutment)
Number of subjects: 0
Study: 25243962

Group type: EXPERIMENTAL
Intervention: Fufang Biejia Ruangan Tablet plus entecavir (Group A, n=56)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Entecavir only (Group B, n=52)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Fufang Biejia Ruangan tablet only (Group C, n=55)
Number of subjects: 163
Study: 22007735

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) techniques (rhythmic initiation, dynamic reversion, isotonic combination)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) techniques
Number of subjects: 15
Study: 20448634

Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Interval Training (AIT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise Training (CMT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (ConFH+)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (ConFH-)
Number of subjects: 44
Study: 18931237

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study: 16093743

Group type: EXPERIMENTAL
Intervention: Women with FMS
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Women who reported rape
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no FMS)
Number of subjects: 105
Study: 12131110

Group type: EXPERIMENTAL
Intervention: Gabapentin (1,200 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 10080511

Group type: EXPERIMENTAL
Intervention: Once-daily vigabatrin administration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Twice-daily vigabatrin administration
Number of subjects: 50
Study: 7743571

Group type: EXPERIMENTAL
Intervention: 2 MAC HAL-N2O
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 MAC HAL-N2O
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 MAC ISO-N2O
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2 MAC ISO-N2O
Number of subjects: 24
Study: 1559299

Group type: EXPERIMENTAL
Intervention: Biosynthetic growth hormone (GH) for 6 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 14
Study: 3876763

Group type: EXPERIMENTAL
Intervention: Physical activity recall in a randomized, one-year exercise trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity recall in two worksite health promotion projects
Number of subjects: 0
Study: 30531205

Group type: EXPERIMENTAL
Intervention: Shift-and-persist psychological strategy
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Shifting and persisting as separate variables
Number of subjects: 645
Study: 30587235

Group type: EXPERIMENTAL
Intervention: SBIRT toolkit implementation
Number of subjects: 2562

Group type: COMPARATOR
Intervention: Usual care (wait-list control)
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Nurse surveys on smoking cessation activities
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Nurse surveys on SBIRT use
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Baseline capacity assessment and implementation fidelity survey
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Structured interview with site coordinators
Number of subjects: 2562
Study: 27233465

Group type: EXPERIMENTAL
Intervention: Neuro-retinal rim area (NRA) measurement in glaucoma subjects
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Neuro-retinal rim area (NRA) measurement in healthy subjects
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Follow-up of glaucoma progression using NRA measurement
Number of subjects: 56
Study: 23361591

Group type: EXPERIMENTAL
Intervention: Histidine supplementation (4 g/day for 12 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (4 g/day for 12 weeks)
Number of subjects: 100
Study: 21987912

Group type: EXPERIMENTAL
Intervention: Sport stacking
Number of subjects: 32

Group type: COMPARATOR
Intervention: Arts/crafts
Number of subjects: 32
Study: 19845233

Group type: EXPERIMENTAL
Intervention: Alpha tocopherol (525 IU) administered orally at 48 hr, 24 hr, and in the morning prior to coronary procedures
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo compound administered orally at 48 hr, 24 hr, and in the morning prior to coronary procedures
Number of subjects: 103
Study: 16895709

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study: 15055365

Group type: EXPERIMENTAL
Intervention: Eye gaze cue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arrow cue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cued targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled attention
Number of subjects: 0
Study: 11340314

Group type: EXPERIMENTAL
Intervention: Cold water stimuli (10-12 degrees C) applied as a Kneipp face shower for 10 seconds followed by a cold wet pack at the neck for 1 minute.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Warm water stimuli (34-36 degrees C) applied identically to cold stimuli.
Number of subjects: 24
Study: 9404414

Group type: EXPERIMENTAL
Intervention: Blood pressure measurements taken by a cardiologist (specialist)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Blood pressure measurements taken by training doctors (six doctors in training)
Number of subjects: 180
Study: 8200011

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day + omega-3 polyunsaturated fatty acids (n3-PUFA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Simvastatin 10 mg/day
Number of subjects: 39
Study: 3709642

Group type: EXPERIMENTAL
Intervention: sublingual isosorbide dinitrate (ISDN) 5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 28717981

Group type: EXPERIMENTAL
Intervention: Education- and strengths-based counselling programme (three sessions) incorporated into routine clinic visits.
Number of subjects: 519

Group type: COMPARATOR
Intervention: Usual care (control).
Number of subjects: 519
Study: 27664531

Group type: EXPERIMENTAL
Intervention: Self-compassion meditation training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 80
Study: 24785951

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Injectable contraception
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Hormonal implants
Number of subjects: 1785

Group type: COMPARATOR
Intervention: No contraception
Number of subjects: 1785
Study: 22730912

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with methylene blue 450 μg/mL and low-power laser
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT) with wavelength 660 nm, power of 30 mW, fluence of 7.5 J/cm(2)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fluconazole 100 mg/day for 14 days
Number of subjects: 21
Study: 20970760

Group type: EXPERIMENTAL
Intervention: Structured aerobic exercise regimen (weekly supervised exercise sessions over a 10-week period, including education, warm-up, 30 minutes of aerobic exercise, and cool down, with exercise intensity adjusted to reach a heart rate goal of 60% of the participant's estimated maximal heart rate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-activity group (exercising ≥ 90 minutes per week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-activity group (exercising < 90 minutes per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 18563970

Group type: EXPERIMENTAL
Intervention: Listening to 'Rhapsody on a Theme of Paganini, Op. 43, Variation 18' by Rachmaninoff using a Continuous Response Digital Interface (CRDI) dial.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Listening to 'Rhapsody on a Theme of Paganini, Op. 43, Variation 18' by Rachmaninoff.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparative analysis based on developmental statuses (normally developing, gifted, special needs).
Number of subjects: 60
Study: 16001382

Group type: EXPERIMENTAL
Intervention: Anecortave acetate 15 mg for depot suspension
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 12471300

Group type: EXPERIMENTAL
Intervention: Euhydrated hot (EH)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dehydrated hot (DH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Euhydrated neutral (EN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dehydrated neutral (DN)
Number of subjects: 10
Study: 10601917

Group type: EXPERIMENTAL
Intervention: Intravaginally administered moistened misoprostol tablets (800 microg, repeated 24 hours later if needed)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mifepristone (600 mg) followed by oral misoprostol (400 microg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intravaginally administered moistened misoprostol tablets
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mifepristone and oral misoprostol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 7793544

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 118

Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: droperidol 1 mg
Number of subjects: 118
Study: 2074205

Group type: EXPERIMENTAL
Intervention: Retransfusion of shed mediastinal blood
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no retransfusion)
Number of subjects: 20
Study: 6157007

Group type: EXPERIMENTAL
Intervention: Azathioprine therapy (2 mg/kg body weight daily)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Non-treated control group
Number of subjects: 56
Study: 30787666

Group type: EXPERIMENTAL
Intervention: 60/60 s LV-HIIT
Number of subjects: 10

Group type: COMPARATOR
Intervention: 30/30 s LV-HIIT
Number of subjects: 10
Study: 28521540

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: LMWH/VKA therapy
Number of subjects: 0
Study: 25977516

Group type: EXPERIMENTAL
Intervention: Physician-diagnosed sleep apnea (PDSA)
Number of subjects: 4395

Group type: EXPERIMENTAL
Intervention: Habitual snoring (HS)
Number of subjects: 4395

Group type: COMPARATOR
Intervention: Neither HS nor PDSA (unaffected)
Number of subjects: 4395
Study: 24015632

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy and adenoidectomy
Number of subjects: 113

Group type: COMPARATOR
Intervention: Coblation adenoidectomy only
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Chronic tonsillitis group
Number of subjects: 113

Group type: COMPARATOR
Intervention: Non-chronic tonsillitis group
Number of subjects: 113
Study: 21301819

Group type: EXPERIMENTAL
Intervention: MK-0249 (10 mg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MK-0249 (50 mg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 19585107

Group type: EXPERIMENTAL
Intervention: acute tryptophan depletion (ATD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: tryptophan-supplemented control mixture
Number of subjects: 24
Study: 17722823

Group type: EXPERIMENTAL
Intervention: Methycobal 250 microg intramuscular injection plus acupuncture at Guanyuan (CV 4), Shenshu (BL 23), Ciliao (BL 32), Huiyang (BL 35), once every day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Methycobal 250 microg intramuscular injection, once every other day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups (Methycobal with and without acupuncture)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Methycobal plus acupuncture
Number of subjects: 70
Study: 15096240

Group type: EXPERIMENTAL
Intervention: Paravertebral injection of radio‐opaque dye (10 ml) with co‐administration of 20 ml of local anaesthetics, ventral to the endothoracic fascia
Number of subjects: 28

Group type: COMPARATOR
Intervention: Paravertebral injection of radio‐opaque dye (10 ml) without co‐administration of local anaesthetics, dorsal to the endothoracic fascia
Number of subjects: 28
Study: 11319433

Group type: EXPERIMENTAL
Intervention: Open wedge medial osteotomy
Number of subjects: 33